Welcome to our dedicated page for 3M news (Ticker: MMM), a resource for investors and traders seeking the latest updates and insights on 3M stock.
3M Company (NYSE: MMM), originally known as Minnesota Mining and Manufacturing, is a global conglomerate that has been a pivotal innovator since its inception in 1902. The company excels in leveraging science and technology to create a diverse range of products that impact various sectors. As of the second quarter of 2024, 3M is structured into three core business segments: Safety and Industrial, Transportation and Electronics, and Consumer. With nearly 50% of its revenue generated outside the Americas, 3M's Safety and Industrial segment leads in net sales.
3M is renowned for its robust research and development capabilities, which have led to significant innovations across multiple industries. Its portfolio includes tens of thousands of products such as adhesives, abrasives, laminates, and healthcare solutions, touching numerous consumer and end markets. The company’s recent achievements include the successful spin-off of its healthcare division into a new entity, Solventum, which began trading on the New York Stock Exchange under the ticker symbol 'SOLV' in April 2024. This strategic move is aimed at enhancing both companies' focus on their core businesses and long-term growth strategies.
Financially, 3M has shown resilience with improved operational performance and double-digit adjusted earnings growth in the first quarter of 2024. The company also completed major legal settlements, including a $10.3 billion agreement with U.S. public water suppliers and a $6.0 billion settlement for Combat Arms Earplugs litigation.
In addition to its financial and strategic developments, 3M continues to invest in expanding its manufacturing capabilities. A notable example is the recent $67 million expansion of its Valley, Nebraska, facility, which is expected to create about 40 new jobs and increase production capacity for personal safety products.
3M’s commitment to innovation and safety is also evident in its efforts to combat counterfeit personal protective equipment (PPE). The company launched the 3M™ Verify app to help ensure the authenticity of its disposable respirators, thereby safeguarding workers' health and safety.
As a company that believes in the power of science to create a brighter world, 3M is dedicated to addressing global challenges and improving lives through its innovative solutions.
3M (NYSE: MMM) has received U.S. EPA approval for its TB Quat Disinfectant Ready-to-Use Cleaner, effective against SARS-CoV-2, with 99.9% germ-killing efficacy in just 60 seconds on hard surfaces. This cleaner, now available for consumer use, addresses cleaning needs in high-traffic areas like hospitals and schools. It is designed to cut through grease, control mildew, and has a pleasant lemon scent. Major retailers, including Home Depot and Target, will carry the product, furthering 3M's commitment to home care amid the pandemic.
3M announced findings on the PREVENA™ Incision Management System at the 30th AAHKS Annual Meeting, showcasing its effectiveness in reducing 90-day surgical site complications (SSCs) and readmission rates in patients undergoing revision total knee arthroplasty (TKAs). Data revealed that patients using PREVENA™ Therapy experienced a 75% lower risk of SSCs and a 66% lower risk of readmission compared to standard care. The study, which involved 294 patients, reinforces the device's value in minimizing healthcare burdens.
3M has launched the PREVENA RESTOR AXIO•FORM™ Incision Management System, designed for post-operative management of orthopedic lower extremity surgeries. This system enhances recovery by stabilizing wounds and reducing edema, featuring an extended therapy time of up to 14 days. It is the third addition to the PREVENA RESTOR™ Therapy portfolio, aimed at minimizing hospital stays and improving patient outcomes. The device is now commercially available and addresses the complex needs of surgical incisions, benefiting both patients and healthcare providers.
3M reported its third-quarter 2020 results, highlighting a 4.5% year-on-year sales growth to $8.4 billion. Notable segments include Health Care, which grew 25.5%, and Safety and Industrial, up 6.9%. Despite improvements, Transportation and Electronics experienced a 7.4% decline. Both GAAP and adjusted earnings were $2.43 per share, down 10.7% year-on-year. Operating cash flow reached $2.5 billion, and dividends paid totaled $847 million. Given ongoing uncertainty from COVID-19, 3M refrained from providing full-year guidance.
3M launched the 3M™ Visual Attention Software (VAS) at the Adobe MAX 2020 Creativity Conference, providing graphic designers with a tool that acts like a 'visual spellcheck for design'. This AI-driven plugin for Adobe® Photoshop® analyzes visual content, offering insights on what captures attention quickly. It produces reports such as Heatmap and Gaze Sequence to inform design decisions without costly market research. 3M aims to enhance creativity with data-driven insights, demonstrating its commitment to digital innovation and consumer engagement.
3M Littmann Stethoscopes and Eko have announced a collaboration to launch the 3M Littmann CORE Digital Stethoscope. This innovative device integrates analog and digital auscultation, leveraging Eko's AI and software for enhanced heart murmur detection. Key features include sound amplification, active noise cancellation, and telemedicine software access, improving clinician confidence and patient care. The stethoscope is designed for both in-person and remote consultations, marking a significant advancement in auscultation technology.
3M (NYSE: MMM) announced its third-quarter 2020 earnings conference call scheduled for Tuesday, October 27, 2020, at 8 a.m. CDT. Investors can participate by calling (800) 762-2596 in the U.S. or +1 (212) 231-2916 internationally. The conference call will be webcast live and available for replay on 3M’s Investor Relations website. With $32 billion in sales and 96,000 employees, 3M focuses on solving global challenges through innovation.
3M and Discovery Education announced Anika Chebrolu, a 14-year-old from Frisco, Texas, as the winner of the 2020 3M Young Scientist Challenge. Anika's innovative research utilized in-silico methodologies to identify a molecule that could potentially bind to the SARS-CoV-2 spike protein, suggesting a new avenue for COVID-19 treatment. She will receive a $25,000 prize and recognition as America’s Top Young Scientist. The challenge emphasized the importance of STEM education, particularly during the pandemic, and celebrated young innovators through virtual events.
The 3M State of Science Index (SOSI) 2020 reveals increased trust in science due to COVID-19, with 89% of respondents expressing confidence in scientific endeavors. The survey highlights the importance of sustainable solutions, social justice, and diversity in STEM fields. Despite a rise in pro-science sentiment, a significant portion of the population remains unaware of science's everyday impact. The findings emphasize the need for collaboration between governments and businesses to tackle global challenges, particularly in health and environmental issues.
3M is enhancing global efforts to combat fraud related to its personal protective equipment amid the ongoing pandemic. The company has initiated legal action against profiteers, submitting 19 lawsuits and receiving judicial support in nine cases. Key steps include establishing hotlines to report fraud and collaborating with law enforcement to seize around 3.5 million counterfeit respirators worldwide. Notably, 3M has committed to not raising respirator prices during this crisis and has engaged with major e-marketplaces to eliminate fraudulent listings.